Functional crosstalk between β2-adrenoreceptor and muscarinic acetylcholine receptor: Implications for gene-gene interactions and bronchodilatory responses in patients with asthma and COPD

Current Pharmacogenomics and Personalized Medicine

Volumn 6, Issue 4, 2008, Pages 302-319

  Yoshikawa, Takahiro ^a   Kanazawa, Hiroshi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic obstructive pulmonary disease (COPD); G protein coupled receptor (GPCR); Health related quality of life (HRQoL); Muscarinic acetylcholine receptor antagonist; 2 Adrenoreceptor polymorphism

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIACYLGLYCEROL; FENOTEROL; FLUTICASONE PROPIONATE; FORMOTEROL; G PROTEIN COUPLED RECEPTOR; GUANOSINE TRIPHOSPHATASE; INOSITOL 1,4,5 TRISPHOSPHATE; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PHOSPHOLIPASE C BETA; PLACEBO; PROTEIN KINASE C; SALBUTAMOL; SALMETEROL; SHORT ACTING DRUG; TERBUTALINE; THEOPHYLLINE; TIOTROPIUM BROMIDE; TRIAMCINOLONE;

ADD ON THERAPY; AMINO ACID SUBSTITUTION; ASTHMA; BRONCHODILATATION; BRONCHOSPASM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DNA POLYMORPHISM; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG WITHDRAWAL; FORCED EXPIRATORY VOLUME; GENE INTERACTION; GENETIC EPISTASIS; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MOLECULAR INTERACTION; MONOTHERAPY; NONHUMAN; PATHOPHYSIOLOGY; PHARMACOGENETICS; PROTEIN STRUCTURE; QUALITY OF LIFE; REVIEW; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT; VAGUS TONE;

EID: 67649304690     PISSN: 18756921     EISSN: 18756913     Source Type: Journal    
DOI: 10.2174/187569208786733857     Document Type: Review

References (168)

1. Aaron, S. D.; Vandemheen, K. L.; Fergusson, D.; Maltais, F.; Bourbeau, J.; Goldstein, R.; Balter, M.; O'Donnell, D.; McIvor, A.; Sharma, S.; Bishop, G.; Anthony, J.; Cowie, R.; Field, S.; Hirsch, A.; Hernandez, P.; Rivington, R.; Road, J.; Hoffstein, V.; Hodder, R.; Marciniuk, D.; McCormack, D.; Fox, G.; Cox, G.; Prins, H. B.; Ford, G.; Bleskie, D.; Doucette, S.; Mayers, I.; Chapman, K.; Zamel, N. and FitzGerald, M. Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium. (2007) Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann. Intern. Med. 146, 545-555.
2. Adjers, K.; Pessi, T.; Karjalainen, J.; Huhtala, H. and Hurme, M. (2004) Epistatic effect of IL1A and IL4RA genes on the risk of atopy. J. Allergy Clin. Immunol. 113, 445-447.
3. Adjers, K.; Karjalainen, J.; Pessi, T.; Eklund, C. and Hurme M. (2005) Epistatic effect of TLR4 and IL4 genes on the risk of asthma in females. Int. Arch. Allergy Immunol. 138, 251-256.
4. Amrani, Y. and Panettieri, R. A. Jr. (2002) Modulation of calcium homeostasis as a mechanism for altering smooth muscle responsiveness in asthma. Curr. Opin. Allergy Clin. Immunol. 2, 39-45.
5. Aziz, I.; Hall, I. P.; McFarlane, L. C. and Lipworth, B. J. (1998) Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma. J. Allergy Clin. Immunol. 101, 337-341.
6. Bai, T. R.; Zhou, D.; Aubert, J. D.; Lizee, G.; Hayashi, S. and Bondy, G. P. (1993) Expression of beta 2-adrenergic receptor mRNA in peripheral lung in asthma and chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 8, 325-333.
7. Baldwin, J. M. (1993) The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 12, 1693-1703.
8. Barnes, P. J. (1986) Neural control of human airways in health and disease. Am. Rev. Respir. Dis. 134, 1289-1314.
9. Barnes, P. J. (1993) Muscarinic receptor subtypes in airways. Life Sci. 52, 521-527.
10. Barnes, P. J. (1995) Inhaled glucocorticoids for asthma. N. Engl. J. Med. 332, 868-875.
11. Barnes, P. J. (1999) Novel approaches and targets for treatment of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160, S72-S79.
12. Beasley, R.; Roche, W. R.; Roberts, J. A. and Holgate, S. T. (1989) Cellular events in the bronchi in mild asthma and after bronchial provocation. Am. Rev. Respir. Dis. 139, 806-817.
13. Belmonte, K. E. (2005) Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2, 297-304.
14. Billington, C. K. and Penn, R. B. (2003) Signaling and regulation of G protein-coupled receptors in airway smooth muscle. Respir. Res. 4, 2.
15. Bleecker, E. R.; Yancey, S. W.; Baitinger, L. A.; Edwards, L. D.; Klotsman, M.; Anderson, W. H. and Dorinsky, P. M. (2006) Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma. J. Allergy Clin. Immunol. 118, 809-816.
16. Bleecker, E. R.; Postma, D. S.; Lawrance, R. M.; Meyers, D. A.; Ambrose, H. J. and Goldman, M. (2007) Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies. Lancet 370, 2118-2125.
17. Bourne, H. R. (1997) How receptors talk to trimeric G proteins. Curr. Opin. Cell Biol. 9, 134-142.
18. Boushey, H. A. (1984) The role of the parasympathetic system in the regulation of bronchial smooth muscle. Eur. J. Respir. Dis. Suppl. 135, 80-90.
19. Bramley, A. M.; Thomson, R. J.; Roberts, C. R. and Schellenberg, R. R. (1994) Hypothesis: excessive bronchoconstriction in asthma is due to decreased airway elastance. Eur. Respir J. 7, 337-341.
20. Braun, S. R.; McKenzie, W. N.; Copeland, C.; Knight, L. and Ellersieck, M. (1989) A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease. Arch. Intern. Med. 149, 544-547.
21. Brusasco, V.; Hodder, R.; Miravitlles, M.; Korducki, L.; Towse, L. and Kesten, S. (2003) Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax 58, 399-404.
22. Budd, D. C.; Challiss, R. A.; Young, K. W. and Tobin, A. B. (1999) Cross talk between m3-muscarinic and beta 2-adrenergic receptors at the level of receptor phosphorylation and desensitization. Mol. Pharmacol. 56, 813-823.
23. Busse, W.; Nelson, H.; Wolfe, J.; Kalberg, C.; Yancey, S. W. and Rickard, K. A. (1999) Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma. J. Allergy Clin. Immunol. 103, 1075-1080.
24. Calverley, P. M.; Burge, P. S.; Spencer, S.; Anderson, J. A. and Jones, P. W. (2003) Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 58, 659-664.
25. Calverley, P. M. (2004) Reducing the frequency and severity of exacerbations of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 1, 121-124.
26. Cardon, L. R. and Bell, J. I. (2001) Association study designs for complex diseases. Nat. Rev. Genet. 2, 91-99.
27. Caulfield, M. P. and Birdsall, N. J. (1998) International union of pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev. 50, 279-290.
28. Chiba, Y.; Murata, M.; Ushikubo, H.; Yoshikawa, Y.; Saitoh, A.; Sakai, H.; Kamei, J. and Misawa, M. (2005) Effect of cigarette smoke exposure in vivo on bronchial smooth muscle contractility in vitro in rats. Am. J. Respir. Cell Mol. Biol. 33, 574-581.
29. Cho S. H.; Oh, S. Y.; Bahn, J. W.; Choi, J. Y.; Chang, Y. S.; Kim, Y. K.; Min, K. U. and Kim Y. Y. (2005) Association between bronchodilating response to short-acting beta-agonist and non-synonymous single-nucleotide polymorphisms of beta-adrenoceptor gene. Clin. Exp. Allergy 35, 1162-1167.
30. Choudhry, S.; Ung, N.; Avila, P. C.; Ziv, E.; Nazario, S.; Casal, J.; Torres, A.; Gorman, J. D.; Salari, K.; Rodriguez-Santana, J. R.; Toscano, M.; Sylvia, J. S.; Alioto, M.; Castro, R. A.; Salazar, M.; Gomez, I.; Fagan, J. K.; Salas, J.; Clark, S.; Lilly, C.; Matallana, H.; Selman, M.; Chapela, R.; Sheppard, D.; Weiss, S. T.; Ford, J. G.; Boushey, H. A.; Drazen, J. M.; Rodriguez-Cintron, W.; Silverman, E. K. and Burchard, E. G. (2005) Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am. J. Respir. Crit. Care Med. 171, 563-570.
31. Clapham, D. E. and Neer, E. J. (1993) New roles for G-protein beta gamma-dimers in transmembrane signalling. Nature 365, 403-406.
32. Colhoun, H. M.; McKeigue, P. M. and Davey Smith, G. (2003) Problems of reporting genetic associations with complex outcomes. Lancet 361, 865-872.
33. Conolly, M. E. and Greenacre, J. K. (1976) The lymphocyte beta-adrenoceptor in normal subjects and patients with bronchial asthma: the effect of different forms of treatment on receptor function. J. Clin. Invest. 58, 1307-1316.
34. Contopoulos-Ioannidis, D. G.; Manoli, E. N. and Ioannidis, J. P. (2005) Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes. J. Allergy Clin. Immunol. 115, 963-972.
35. Cordell, H. J. (2002) Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum. Mol. Genet. 11, 2463-2468.
36. Daaka, Y.; Luttrell, L. M. and Lefkowitz, R. J. (1997) Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 390, 88-91.
37. Daniels, S. E.; Bhattacharrya, S.; James, A.; Leaves, N. I.; Young, A.; Hill, M. R.; Faux, J. A.; Ryan, G. F.; le Söuef, P. N.; Lathrop, G. M.; Musk, A. W. and Cookson, W. O. (1996) A genome-wide search for quantitative trait loci underlying asthma. Nature 383, 247-250.
38. Davis, C. and Kannan, M. S. (1987) Sympathetic innervation of human tracheal and bronchial smooth muscle. Respir. Physiol. 68, 53-61.
39. Davies, B.; Brooks, G. and Devoy, M. (1998) The efficacy and safety of salmeterol compared to theophylline: meta-analysis of nine controlled studies. Respir. Med. 92, 256-263.
40. Deichmann, K. A.; Schmidt, A.; Heinzmann, A.; Kruse, S.; Forster, J. and Kuehr, J. (1999) Association studies on beta2-adrenoceptor polymorphisms and enhanced IgE responsiveness in an atopic population. Clin. Exp. Allergy 29, 794-799.
41. de Jongste, J. C.; Mons, H.; Bonta, I. L. and Kerrebijn, K. F. (1987) In vitro responses of airways from an asthmatic patient. Eur. J. Respir. Dis. 71, 23-29.
42. de Jongste, J. C.; Mons, H.; Bonta, I. L. and Kerrebijn, K. F. (1989) Relaxation of human peripheral airway smooth muscle in vitro does not correlate with severity of chronic airflow limitation in vivo. Pulm. Pharmacol. 2, 75-79.
43. Deshpande, D. A.; White, T. A.; Dogan, S.; Walseth, T. F.; Panettieri, R. A. and Kannan, M. S. (2005) CD38/cyclic ADP-ribose signaling: role in the regulation of calcium homeostasis in airway smooth muscle. Am. J. Physiol. Lung Cell Mol. Physiol. 288, L773-L788.
44. Dewar, J. C.; Wilkinson, J.; Wheatley, A.; Thomas, N. S.; Doull, I.; Morton, N.; Lio, P.; Harvey, J. F.; Liggett, S. B.; Holgate, S. T. and Hall, I. P. (1997) The glutamine 27 beta2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families. J. Allergy Clin. Immunol. 100, 261-265.
45. Donfack, J.; Kogut, P.; Forsythe, S.; Solway, J. and Ober, C. (2003) Sequence variation in the promoter region of the cholinergic receptor muscarinic 3 gene and asthma and atopy. J. Allergy Clin. Immunol. 111, 527-532.
46. Donohue, J. F.; van Noord, J. A.; Bateman, E. D.; Langley, S. J.; Lee, A.; Witek, T. J. Jr.; Kesten, S. and Towse, L. (2002) A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 122, 47-55.
47. Eglen, R. M.; Hegde, S. S. and Watson, N. (1996) Muscarinic receptor subtypes and smooth muscle function. Pharmacol. Rev. 48, 531-565.
48. Etienne-Manneville, S. and Hall, A. (2002) Rho GTPases in cell biology. Nature 420, 629-635.
49. Fenech, A. G.; Ebejer, M. J.; Felice, A. E.; Ellul-Micallef, R. and Hall, I. P. (2001) Mutation screening of the muscarinic M(2) and M(3) receptor genes in normal and asthmatic subjects. Br. J. Pharmacol. 133, 43-48.
50. Fernandes, L. B.; Fryer, A. D. and Hirshman, C. A. (1992) M2 muscarinic receptors inhibit isoproterenol-induced relaxation of canine airway smooth muscle. J. Pharmacol. Exp. Ther. 262, 119-126.
51. Fisher, J. T.; Vincent, S. G.; Gomeza, J.; Yamada, M. and Wess, J. (2004) Loss of vagally mediated bradycardia and bronchoconstriction in mice lacking M2 or M3 muscarinic acetylcholine receptors. FASEB J. 18, 711-713.
52. Fryer, A. D. and Maclagan, J. (1984) Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig. Br. J. Pharmacol. 83, 973-978.
53. Fryer, A. D. and Jacoby, D. B. (1998) Muscarinic receptors and control of airway smooth muscle. Am. J. Respir. Crit. Care Med. 158, S154-S160.
54. Galant, S. P.; Duriseti, L.; Underwood, S.; Allred, S. and Insel, P. A. (1980) Beta adrenergic receptors of polymorphonuclear particulates in bronchial asthma. J. Clin. Invest. 65, 577-585.
55. Giembycz, M. A. and Newton, R. (2006) Beyond the dogma: novel beta2-adrenoceptor signalling in the airways. Eur. Respir. J. 27, 1286-1306.
56. Gosens, R.; Zaagsma, J.; Grootte Bromhaar, M.; Nelemans, A. and Meurs, H. (2004) Acetylcholine: a novel regulator of airway smooth muscle remodelling? Eur. J. Pharmacol. 500, 193-201.
57. Gosens, R.; Zaagsma, J.; Meurs, H. and Halayko, A. J. (2006) Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir. Res. 7, 73.
58. Green, S. A.; Cole, G.; Jacinto, M.; Innis, M. and Liggett, S. B. (1993) A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J. Biol. Chem. 268, 23116-23121.
59. Green, S. A.; Turki, J.; Bejarano, P.; Hall, I. P. and Liggett, S. B. (1995) Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 13, 25-33.
60. Gross, N. J. and Skorodin, M. S. (1984) Role of the parasympathetic system in airway obstruction due to emphysema. N. Engl. J. Med. 311, 421-425.
61. Gross, N. J. (2006) Anticholinergic agents in asthma and COPD. Eur. J. Pharmacol. 533, 36-39.
62. Gwilt, C. R.; Donnelly, L. E. and Rogers, D. F. (2007) The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation? Pharmacol. Ther. 115, 208-222.
63. Haddad, E. B.; Mak, J. C.; Belvisi, M. G.; Nishikawa, M.; Rousell, J. and Barnes, P. J. (1996) Muscarinic and beta-adrenergic receptor expression in peripheral lung from normal and asthmatic patients. Am. J. Physiol. 270, L947-L953.
64. Hall, I. P.; Wheatley, A.; Wilding, P. and Liggett, S. B. (1995) Association of Glu 27 beta 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 345, 1213-1214.
65. Hall, I. P. (1996) Beta 2 adrenoceptor polymorphisms: are they clinically important? Thorax 51, 351-353.
66. Hall, I. P. (2000) Second messengers, ion channels and pharmacology of airway smooth muscle. Eur. Respir. J. 15, 1120-1127.
67. Han, S. J.; Hamdan, F. F.; Kim, S. K.; Jacobson, K. A.; Bloodworth, L. M.; Li, B. and Wess, J. (2005) Identification of an agonist-induced conformational change occurring adjacent to the ligand-binding pocket of the M3 muscarinic acetylcholine receptor. J. Biol. Chem. 280, 34849-34858.
68. Hancox, R. J.; Sears, M. R. and Taylor, D. R. (1998) Polymorphism of the beta2-adrenoceptor and the response to long-term beta2-agonist therapy in asthma. Eur. Respir. J. 11, 589-593.
69. Hizawa, N.; Makita, H.; Nasuhara, Y.; Betsuyaku, T.; Itoh, Y.; Nagai, K.; Hasegawa, M. and Nishimura, M. (2007) beta 2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD. Chest 132, 1485-1492.
70. Ho, L. I.; Harn, H. J.; Chen, C. J. and Tsai, N. M. (2001) Polymorphism of the beta 2-adrenoceptor in COPD in Chinese subjects. Chest 120, 1493-1499.
71. Hogg, J. C. (2004) Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364, 709-721.
72. Holloway, J. W.; Dunbar, P. R.; Riley, G. A.; Sawyer, G. M.; Fitzharris, P. F.; Pearce, N.; Le Gros, G. S. and Beasley, R. (2000) Association of beta2-adrenergic receptor polymorphisms with severe asthma. Clin. Exp. Allergy 30, 1097-1103.
73. Israel, E.; Drazen, J. M.; Liggett, S. B.; Boushey, H. A.; Cherniack, R. M.; Chinchilli, V. M.; Cooper, D. M.; Fahy, J. V.; Fish, J. E.; Ford, J. G.; Kraft, M.; Kunselman, S.; Lazarus, S. C.; Lemanske, R. F.; Martin, R. J.; McLean, D. E.; Peters, S. P.; Silverman, E. K.; Sorkness, C. A.; Szefler, S. J.; Weiss, S. T. and Yandava, C. N. (2000) The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am. J. Respir. Crit. Care Med. 162, 75-80.
74. Israel, E.; Chinchilli, V. M.; Ford, J. G.; Boushey, H. A.; Cherniack, R.; Craig, T. J.; Deykin, A.; Fagan, J. K.; Fahy, J. V.; Fish, J.; Kraft, M.; Kunselman, S. J.; Lazarus, S. C.; Lemanske, R. F. Jr.; Liggett, S. B.; Martin, R. J.; Mitra, N.; Peters, S. P.; Silverman, E.; Sorkness, C. A.; Szefler, S. J.; Wechsler, M. E.; Weiss, S. T. and Drazen, J. M. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. (2004) Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 364, 1505-1512.
75. Ji, T. H.; Grossmann, M. and Ji, I. (1998) G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J. Biol. Chem. 273, 17299-17302.
76. Johnson, M. (1992) Mechanisms of action of β-adrenoceptor agonists. In Beta-Agonists in the Treatment of Asthma; Costello, J. F. and Mann, R. D.; Eds.; Parthenon: Carnforth, pp. 27-42.
77. Jones, T. R.; Kannan, M. S. and Daniel, E. E. (1980) Ultrastructural study of guinea pig tracheal smooth muscle and its innervation. Can. J. Physiol. Pharmacol. 58, 974-983.
78. Kelsen, S. G.; Higgins, N. C.; Zhou, S.; Mardini, I. A. and Benovic, J. L. (1995) Expression and function of the beta-adrenergic receptor coupled-adenylyl cyclase system on human airway epithelial cells. Am. J. Respir. Crit. Care Med. 152, 1774-1783.
79. Kips, J. C. and Pauwels, R. A. (2001) Long-acting inhaled beta(2)-agonist therapy in asthma. Am. J. Respir. Crit. Care Med. 164, 923-932.
80. K6oike, K.; Yamashita, Y.; Horinouchi, T.; Yamaki, F. and Tanaka, Y. (2004) cAMP-independent mechanism is significantly involved in beta2-adrenoceptor-mediated tracheal relaxation. Eur. J. Pharmacol. 492, 65-70.
81. Kotani, Y.; Nishimura, Y.; Maeda, H. and Yokoyama, M. (1999) Beta2-adrenergic receptor polymorphisms affect airway responsiveness to salbutamol in asthmatics. J. Asthma 36, 583-590.
82. Koyama, S.; Rennard, S. I. and Robbins, R. A. (1992) Acetylcholine stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. Am. J. Physiol. 262, L466-L471.
83. Laitinen, A. (1985) Autonomic innervation of the human respiratory tract as revealed by histochemical and ultrastructural methods. Eur. J. Respir. Dis. (Suppl.) 140, 1-42.
84. Lambert, R. K.; Wiggs, B. R.; Kuwano, K.; Hogg, J. C. and Paré, P. D. (1993) Functional significance of increased airway smooth muscle in asthma and COPD. J. Appl. Physiol. 74, 2771-2781.
85. Lee, D. K.; Currie, G. P.; Hall, I. P.; Lima, J. J. and Lipworth, B. J. (2004) The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol. Br. J. Clin. Pharmacol. 57, 68-75.
86. Lefkowitz, R. J. and Shenoy, S. K. (2005) Transduction of receptor signals by beta-arrestins. Science 308, 512-517.
87. Lefkowitz, R. J. (2007) Seven transmembrane receptors: something old, something new. Acta Physiol. 190, 9-19.
88. Levitt, R. C.; Eleff, S. M.; Zhang, L. Y.; Kleeberger, S. R. and Ewart, S. L. (1995) Linkage homology for bronchial hyperresponsiveness between DNA markers on human chromosome 5q31-q33 and mouse chromosome 13. Clin. Exp. Allergy 25 (S2), 61-63.
89. Lima, J. J.; Thomason, D. B.; Mohamed, M. H.; Eberle, L. V.; Self, T. H. and Johnson, J. A. (1999) Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics. Clin. Pharmacol. Ther. 65, 519-525.
90. Lin, M.; Aquilante, C.; Johnson, J. A. and Wu, R. (2005) Sequencing drug response with HapMap. Pharmacogenomics J. 5, 149-156.
91. Lin, M.; Li, H.; Hou, W.; Johnson, J. A. and Wu, R. (2007) Modeling sequence-sequence interactions for drug response. Bioinformatics 23, 1251-1257.
92. Lipworth, B. J.; Hall, I. P.; Aziz, I.; Tan, K. S. and Wheatley, A. (1999a) Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy. Clin. Sci. (Lond). 96, 253-259.
93. Lipworth, B. J.; Hall, I. P.; Tan, S.; Aziz, I. and Coutie, W. (1999b) Effects of genetic polymorphism on ex vivo and in vivo function of beta2-adrenoceptors in asthmatic patients. Chest 115, 324-328.
94. Liu, M. and Simon, M. I. (1996) Regulation by cAMP-dependent protein kinease of a G-protein-mediated phospholipase C. Nature 382, 83-87.
95. Lou, X. Y.; Chen, G. B.; Yan, L.; Ma, J. Z.; Zhu, J.; Elston, R. C. and Li, M. D. (2007) A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am. J. Hum. Genet. 80, 1125-1137.
96. Lundback, B.; Rawlinson, D. W. and Palmer, J. B. (1993) Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group. Thorax 48, 148-153.
97. Lutz, S.; Freichel-Blomquist, A.; Yang, Y.; Rümenapp, U.; Jakobs, K. H.; Schmidt, M. and Wieland, T. (2005) The guanine nucleotide exchange factor p63RhoGEF, a specific link between Gq/11-coupled receptor signaling and RhoA. J. Biol. Chem. 280, 11134-11139.
98. Maddox, L. and Schwartz, D. A. (2002) The pathophysiology of asthma. Annu. Rev. Med. 53, 477-498.
99. Maeda, Y.; Hizawa, N.; Jinushi, E.; Honda, A.; Takahashi, D.; Fukui, Y.; Konno, S.; Shimizu, T.; Shimizu, H.; Yamaguchi, E. and Nishimura, M. (2006) Polymorphisms in the muscarinic receptor 1 gene confer susceptibility to asthma in Japanese subjects. Am. J. Respir. Crit. Care Med. 174, 1119-1124.
100. Marsh, D. G.; Neely, J. D.; Breazeale, D. R.; Ghosh, B.; Freidhoff, L. R.; Ehrlich-Kautzky, E.; Schou, C.; Krishnaswamy, G. and Beaty, T. H. (1994) Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 264, 1152-1156.
101. Martinez, F. D.; Graves, P. E.; Baldini, M.; Solomon, S. and Erickson, R. (1997) Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J. Clin. Invest. 100, 3184-3188.
102. Matheson, M. C.; Ellis, J. A.; Raven, J.; Johns, D. P.; Walters, E. H. and Abramson, M. J. (2006) Beta2-adrenergic receptor polymorphisms are associated with asthma and COPD in adults. J. Hum. Genet. 51, 943-951.
103. Matthiesen, S.; Bahulayan, A.; Kempkens, S.; Haag, S.; Fuhrmann, M.; Stichnote, C.; Juergens, U. R. and Racké, K. (2006) Muscarinic receptors mediate stimulation of human lung fibroblast proliferation. Am. J. Respir. Cell Mol. Biol. 35, 621-627.
104. McGraw, D. W. and Liggett, S. B. (2005) Molecular mechanisms of beta2-adrenergic receptor function and regulation. Proc. Am. Thorac. Soc. 2, 292-296.
105. Minette, P. A.; Lammers, J. W.; Dixon, C. M.; McCusker, M. T. and Barnes, P. J. (1989) A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects. J. Appl. Physiol. 67, 2461-2465.
106. Moore, J. H. (2003) The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum. Hered. 56, 73-82.
107. Moore, J. H. (2005) A global view of epistasis. Nat. Genet. 37, 13-14.
108. Molfino, N. A.; Slutsky, A. S.; Julià-Serdà, G.; Hoffstein, V.; Szalai, J. P.; Chapman, K. R.; Rebuck, A. S. and Zamel, N. (1993) Assessment of airway tone in asthma. Comparison between double lung transplant patients and healthy subjects. Am. Rev. Respir. Dis. 148, 1238-1243.
109. Murray, C. J. and Lopez, A. D. (1997) Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349, 1269-1276.
110. Nahorski, S. R.; Tobin, A. B. and Willars, G. B. (1997) Muscarinic M3 receptor coupling and regulation. Life Sci. 60, 1039-1045.
111. National Heart, Lung, and Blood Institute. Global Initiative for Chronic Obstructive Lung Disease (GOLD): global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease (2006 update). National Institutes of Health, Bethesda, MD. Available at GOLD website: http://www.goldcopd.com. Accessed: 24 September 2007.
112. Neer, E. J. (1995) Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80, 249-257.
113. Neves, S. R.; Ram, P. T. and Iyengar, R. (2002) G protein pathways. Science 296, 1636-1639.
114. Neumann, S.; Razen, M.; Habermehl, P.; Meyer, C. U.; Zepp, F.; Kirkpatrick, C. J. and Wessler, I. (2007) The non-neuronal cholinergic system in peripheral blood cells: effects of nicotinic and muscarinic receptor antagonists on phagocytosis, respiratory burst and migration. Life Sci. 80, 2361-2364.
115. Nicodemus, K. K.; Kolachana, B. S.; Vakkalanka, R.; Straub, R. E.; Giegling, I.; Egan, M. F.; Rujescu, D. and Weinberger, D. R. (2007) Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Hum. Genet. 120, 889-906.
116. Nielsen, L. P.; Pedersen, B.; Faurschou, P.; Madsen, F.; Wilcke, J. T. and Dahl, R. (1999) Salmeterol reduces the need for inhaled corticosteroid in steroid-dependent asthmatics. Respir. Med. 93, 863-868.
117. O'Byrne, P. M.; Barnes, P. J.; Rodriguez-Roisin, R.; Runnerstrom, E.; Sandstrom, T.; Svensson, K. and Tattersfield, A. (2001) Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am. J. Respir. Crit. Care Med. 164, 1392-1397.
118. 2 muscarinic receptors in stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 163, 1320-1325.
119. Palmer, L. J.; Silverman, E. S.; Weiss, S. T. and Drazen, J. M. (2002) Pharmacogenetics of asthma. Am. J. Respir. Crit. Care Med. 165, 861-866.
120. Palmer, C. N.; Lipworth, B. J.; Lee, S.; Ismail, T.; Macgregor, D. F. and Mukhopadhyay, S. (2006) Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol. Thorax 61, 940-944.
121. Parameswaran, K.; Janssen, L. J. and O'Byrne, P. M. (2002) Airway hyper-responsiveness and calcium handling by smooth muscle: a "deeper look". Chest 121, 621-624.
122. Pauwels, R. A.; Löfdahl, C. G.; Postma, D. S.; Tattersfield, A. E.; O'Byrne, P. M.; Barnes, P. J. and Ullman, A. (1997) Effect of inhaled formoterol and budesonide on exacerbations of asthma. N. Engl. J. Med. 337, 1405-1411.
123. Pearlman, D. S.; Chervinsky, P.; LaForce, C.; Seltzer, J. M.; Southern, D. L.; Kemp, J. P.; Dockhorn, R. J.; Grossman, J.; Liddle, R. F.; Yancey, S. W.; Cocchetto, D. M.; Alexander, W. J. and Van As, A. (1992) A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N. Engl. J. Med. 327, 1420-1425.
124. Pierce, K. L.; Premont, R. T. and Lefkowitz, R. J. (2002) Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3, 639-650.
125. Postma, D. S.; Bleecker, E. R.; Amelung, P. J.; Holroyd, K. J.; Xu, J.; Panhuysen, C. I.; Meyers, D. A. and Levitt, R. C. (1995) Genetic susceptibility to asthma - bronchial hyperresponsiveness coinherited with a major gene for atopy. N. Engl. J. Med. 333, 894-900.
126. Premont, R. T. and Gainetdinov, R. R. (2007) Physiological roles of G protein-coupled receptor kinases and arrestins. Annu. Rev. Physiol. 69, 511-534.
127. Proskocil, B. J. and Fryer, A. D. (2005) Beta2-agonist and anticholinergic drugs in the treatment of lung disease. Proc. Am. Thorac. Soc. 2, 305-310.
128. Ramsay, C. E.; Hayden, C. M.; Tiller, K. J.; Burton, P. R.; Hagel, I.; Palenque, M.; Lynch, N. R.; Goldblatt, J. and LeSouëf, P. N. (1999) Association of polymorphisms in the beta2-adrenoreceptor gene with higher levels of parasitic infection. Hum. Genet. 104, 269-274.
129. Rana, B. K.; Insel, P. A.; Payne, S. H.; Abel, K.; Beutler, E.; Ziegler, M. G.; Schork, N. J. and O'Connor, D. T. (2007) Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension 49, 96-106.
130. Reihsaus, E.; Innis, M.; MacIntyre, N. and Liggett, S. B. (1993) Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am. J. Respir. Cell Mol. Biol. 8, 334-339.
131. Richardson, P. S. and Sterling, G. M. (1969) Effects of beta-adrenergic receptor blockade on airway conductance and lung volume in normal and asthmatic subjects. Br. Med. J. 3, 143-145.
132. Richardson, J. and Béland, J. (1976) Nonadrenergic inhibitory nervous system in human airways. J. Appl. Physiol. 41, 764-771.
133. Richardson, J. B. (1979) Nerve supply to the lungs. Am. Rev. Respir. Dis. 119, 785-802.
134. Roffel, A. F.; Elzinga, C. R. and Zaagsma, J. (1990) Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle. Pulm. Pharmacol. 3, 47-51.
135. Sakai, H.; Shirai, T.; Yamamoto, M.; Chiba, Y. and Misawa, M. (2005) Involvement of M3 muscarinic receptors in ACh-induced increase in membrane-associated RhoA of rat bronchial smooth muscle. Biol. Pharm. Bull. 28, 625-628.
136. Schulte, G. and Levy, F. O. (2007) Novel aspects of G-protein-coupled receptor signalling - different ways to achieve specificity. Acta Physiol. 190, 33-38.
137. Schultheis, A. H.; Bassett, D. J. and Fryer, A. D. (1994) Ozone-induced airway hyperresponsiveness and loss of neuronal M2 muscarinic receptor function. J. Appl. Physiol. 76, 1088-1097.
138. Sears, M. R.; Taylor, D. R.; Print, C. G.; Lake, D. C.; Li, Q. Q.; Flannery, E. M.; Yates, D. M.; Lucas, M. K. and Herbison, G. P. (1990) Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336, 1391-1396.
139. Selbie, L. A. and Hill, S. J. (1998) G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways. Trends Pharmacol. Sci. 19, 87-93.
140. Skoogh, B. E. (1986) Parasympathetic ganglia in the airways. Bull. Eur. Physiopathol. Respir. 22, 143S-147S.
141. Somlyo, A. P. and Somlyo, A. V. (2003) Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 83, 1325-1358.
142. Spicuzza, L.; Belvisi, M. G.; Birrell, M. A.; Barnes, P. J.; Hele, D. J. and Giembycz, M. A. (2001) Evidence that the anti-spasmogenic effect of the beta-adrenoceptor agonist, isoprenaline, on guinea-pig trachealis is not mediated by cyclic AMP-dependent protein kinase. Br. J. Pharmacol. 133, 1201-1212.
143. Spitzer, W. O.; Suissa, S.; Ernst, P.; Horwitz, R. I.; Habbick, B.; Cockcroft, D.; Boivin, J. F.; McNutt, M.; Buist, A. S. and Rebuck, A. S. (1992) The use of beta-agonists and the risk of death and near death from asthma. N. Engl. J. Med. 326, 501-506.
144. Stengel, P. W.; Yamada, M.; Wess, J. and Cohen, M. L. (2002) M(3)-receptor knockout mice: muscarinic receptor function in atria, stomach fundus, urinary bladder, and trachea. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R1443-R1449.
145. Struckmann, N.; Schwering, S.; Wiegand, S.; Gschnell, A.; Yamada, M.; Kummer, W.; Wess, J. and Haberberger, R. V. (2003) Role of muscarinic receptor subtypes in the constriction of peripheral airways: studies on receptor-deficient mice. Mol. Pharmacol. 64, 1444-1451.
146. Talkowski, M. E.; Kirov, G.; Bamne, M.; Georgieva, L.; Torres, G.; Mansour, H.; Chowdari, K. V.; Milanova, V.; Wood, J.; McClain, L.; Prasad, K.; Shirts, B.; Zhang, J.; O'Donovan, M. C.; Owen, M. J.; Devlin, B. and Nimgaonkar, V. L. (2008) A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Hum. Mol. Genet. 17, 747-758.
147. Tan, S.; Hall, I. P.; Dewar, J.; Dow, E. and Lipworth, B. (1997) Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Lancet 350, 995-999.
148. Tao, F. C.; Tolloczko, B.; Eidelman, D. H. and Martin, J. G. (1999) Enhanced Ca(2+) mobilization in airway smooth muscle contributes to airway hyperresponsiveness in an inbred strain of rat. Am. J. Respir. Crit. Care Med. 160, 446-453.
149. Tayebati, S. K.; El-Assouad, D.; Ricci, A. and Amenta, F. (2002) Immunochemical and immunocytochemical characterization of cholinergic markers in human peripheral blood lymphocytes. J. Neuroimmunol. 132, 147-155.
150. Taylor, D. R.; Drazen, J. M.; Herbison, G. P.; Yandava, C. N.; Hancox, R. J. and Town, G. I. (2000a) Asthma exacerbations during long term beta agonist use: influence of beta2 adrenoceptor polymorphism. Thorax 55, 762-767.
151. Taylor, D. R.; Hancox, R. J.; McRae, W.; Cowan, J. O.; Flannery, E. M.; McLachlan, C. R. and Herbison, G. P. (2000b) The influence of polymorphism at position 16 of the beta2-adrenoceptor on the development of tolerance to beta-agonist. J. Asthma 37, 691-700.
152. Turki, J.; Pak, J.; Green, S. A.; Martin, R. J. and Liggett, S. B. (1995) Genetic Polymorphisms of the beta 2-adrenergic receptor in nocturnal and non-nocturnal asthma: evidence that Gly16 correlates with the nocturnal phenotype. J. Clin. Invest. 95, 1635-1641.
153. Turner, S. W.; Khoo, S. K.; Laing, I. A.; Palmer, L. J.; Gibson, N. A.; Rye, P.; Landau, L. I.; Goldblatt, J. and Le Soüef, P. N. (2004) beta2 adrenoceptor Arg16Gly polymorphism, airway responsiveness, lung function and asthma in infants and children. Clin. Exp. Allergy 34, 1043-1048.
154. Ulbrecht, M.; Hergeth, M. T.; Wjst, M.; Heinrich, J.; Bickeböller, H.; Wichmann, H. E. and Weiss, E. H. (2000) Association of beta 2-adrenoreceptor variants with bronchial hyperresponsiveness. Am. J. Respir. Crit. Care Med. 161, 469-474.
155. 2-adrenoreceptor genotypes with bronchodilatory effect of tiotropium in COPD. Respirology 13, 346-352.
156. Van Koppen, C. J.; Rodrigues De Miranda, J. F.; Beld, A. J.; Van Ginneken, C. A.; Lammers, J. W. and Van Herwaarden, C. L. (1988) Muscarinic receptor sensitivity in airway smooth muscle of patients with
157. van Koppen, C. J.; de Miranda, J. F.; Beld, A. J.; van Herwaarden, C. L.; Lammers, J. W. and van Ginneken, C. A. (1989) Beta adrenoceptor binding and induced relaxation in airway smooth muscle from patients with chronic airflow obstruction. Thorax 44, 28-35.
158. Warren, J. B. and Dalton, N. (1983) A comparison of the bronchodilator and vasopressor effects of exercise levels of adrenaline in man. Clin. Sci. (Lond). 64, 475-479.
159. Wechsler, M. E. and Israel, E. (2005) How pharmacogenomics will play a role in the management of asthma. Am. J. Respir. Crit. Care Med. 172, 12-18.
160. Wechsler, M. E.; Lehman, E.; Lazarus, S. C.; Lemanske, R. F. Jr.; Boushey, H. A.; Deykin, A.; Fahy, J. V.; Sorkness, C. A.; Chinchilli, V. M.; Craig, T. J.; DiMango, E.; Kraft, M.; Leone, F.; Martin, R. J.; Peters, S. P.; Szefler, S. J.; Liu, W. and Israel, E.; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. (2006) beta-Adrenergic receptor polymorphisms and response to salmeterol. Am. J. Respir. Crit. Care Med. 173, 519-526.
161. Weir, T. D.; Mallek, N.; Sandford, A. J.; Bai, T. R.; Awadh, N.; Fitzgerald, J. M.; Cockcroft, D.; James, A.; Liggett, S. B. and Paré, P. D. (1998) beta2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am. J. Respir. Crit. Care Med. 158, 787-791.
162. Wessler, I.; Kirkpatrick, C. J. and Racké, K. (1999) The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems, including humans. Clin. Exp. Pharmacol. Physiol. 26, 198-205.
163. Whicker, S. D.; Armour, C. L. and Black, J. L. (1988) Responsiveness of bronchial smooth muscle from asthmatic patients to relaxant and contractile agonists. Pulm. Pharmacol. 1, 25-31.
164. Wilding, P.; Clark, M.; Thompson Coon, J.; Lewis, S.; Rushton, L.; Bennett, J.; Oborne, J.; Cooper, S. and Tattersfield, A. E. (1997) Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study. BMJ 314, 1441-1446.
165. Williams, S. M.; Ritchie, M. D.; Phillips, J. A. 3rd.; Dawson, E.; Prince, M.; Dzhura, E.; Willis, A.; Semenya, A.; Summar, M.; White, B. C.; Addy, J. H.; Kpodonu, J.; Wong, L. J.; Felder, R. A.; Jose, P. A. and Moore, J. H. (2004) Multilocus analysis of hypertension: a hierarchical approach. Hum. Hered. 57, 28-38.
166. Wilt, T. J.; Niewoehner, D.; MacDonald, R. and Kane, R. L. (2007) Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline. Ann. Intern. Med. 147, 639-653.
167. Yukawa, T.; Ukena, D.; Kroegel, C.; Chanez, P.; Dent, G.; Chung, K. F. and Barnes, P. J. (1990) Beta 2-adrenergic receptors on eosinophils. Binding and functional studies. Am. Rev. Respir. Dis. 141, 1446-1452.
168. Zaagsma, J.; Roffel, A. F. and Meurs, H. (1997) Muscarinic control of airway function. Life Sci. 60, 1061-1068.